Tweaks To CBO Model May Add Another Hurdle To Congressional Drug Pricing Reform Effort
Executive Summary
New model suggests extra hit for accelerated approval drugs. But despite Congress and President Biden looking toward a scaled-backed version of the Build Back Better reconciliation package, many health care politics experts believe drug price negotiation will make it into law this year.